Skip to Content

200 mg T25 (Atazanavir Sulfate 200 mg)

Pill with imprint 200 mg T25 is Blue, Capsule-shape and has been identified as Atazanavir Sulfate 200 mg. It is supplied by Aurobindo Pharma Limited.

Atazanavir is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 200 mg T25

Atazanavir sulfate 200 mg 200 mg T25

Atazanavir Sulfate

Imprint
200 mg T25
Strength
200 mg
Color
Blue
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
National Drug Code (NDC)
65862-0712
Inactive Ingredients
lactose monohydrate, magnesium stearate, FD&C Blue No. 2, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, titanium dioxide, potassium hydroxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.